Commissioned a non GMP facility which added the capability to do early phase development projects in an agile and cost-effective manner. Commissioned the state-of-the-art digitally enabled quality control lab that will support growing biologics operations.
Share this post
SYNGENE INTERNATIONAL Q2FY24 Earnings Call…
Share this post
Commissioned a non GMP facility which added the capability to do early phase development projects in an agile and cost-effective manner. Commissioned the state-of-the-art digitally enabled quality control lab that will support growing biologics operations.